-
公开(公告)号:US20170306306A1
公开(公告)日:2017-10-26
申请号:US15520533
申请日:2015-10-26
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Robert POTTER , Jonathan CHESNUT , Xiquan LIANG
IPC: C12N9/22 , C12N15/90 , C12N2310/20
CPC classification number: C12N9/22 , C07K2319/00 , C07K2319/81 , C12N15/902 , C12N2310/20
Abstract: The present disclosure generally relates to compositions and methods for improving the efficiency of homologous recombination. In particular, the disclosure relates to reagents and the use of such reagents.
-
公开(公告)号:US20200325514A1
公开(公告)日:2020-10-15
申请号:US16736258
申请日:2020-01-07
Inventor: Todd PETERSON , Axel TREFZER , Thomas POEHMERER , Federico KATZEN , Xiquan LIANG
Abstract: The disclosure generally relates to compositions and methods for the production of nucleic acid molecules. In some aspects, the invention allows for the microscale generation of nucleic acid molecules, optionally followed by assembly of these nucleic acid molecules into larger molecules. In some aspects, the invention allows for efficient production of nucleic acid molecules (e.g., large nucleic acid molecules such as genomes).
-
公开(公告)号:US20180195089A1
公开(公告)日:2018-07-12
申请号:US15842664
申请日:2017-12-14
Inventor: Namritha RAVINDER , Korbinian HEIL , Yizhu GUO , Xiquan LIANG , Robert POTTER , Sanjay KUMAR
CPC classification number: C12N15/907 , C12N15/102 , C12N15/11 , C12N2310/3519 , C12P19/34 , C12Q1/686 , C12Q2525/143
Abstract: The present disclosure generally relates to compositions and methods for the genetic modification of cells. In particular, the disclosure relates to CRISPR reagents and the use of such reagents.
-
公开(公告)号:US20160122792A1
公开(公告)日:2016-05-05
申请号:US14775648
申请日:2014-03-14
Inventor: Todd PETERSON , Axel TREFZER , Thomas POEHMERER , Federico KATZEN , Xiquan LIANG
IPC: C12P19/34
CPC classification number: C12P19/34 , C12N15/1031 , C12N15/1093
Abstract: The disclosure generally relates to compositions and methods for the production of nucleic acid molecules. In some aspects, the invention allows for the microscale generation of nucleic acid molecules, optionally followed by assembly of these nucleic acid molecules into larger molecules. In some aspects, the invention allows for efficient production of nucleic acid molecules (e.g., large nucleic acid molecules such as genomes).
-
公开(公告)号:US20220033858A1
公开(公告)日:2022-02-03
申请号:US17327002
申请日:2021-05-21
Inventor: Namritha RAVINDER , Korbinian HEIL , Yizhu GUO , Xiquan LIANG , Robert POTTER , Sanjay KUMAR
Abstract: The present disclosure generally relates to compositions and methods for the genetic modification of cells. In particular, the disclosure relates to CRISPR reagents and the use of such reagents.
-
公开(公告)号:US20210054415A1
公开(公告)日:2021-02-25
申请号:US17093486
申请日:2020-11-09
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Xin YU , Xiquan LIANG , Xavier de MOLLERAT du JEU , Robert Jason POTTER
Abstract: Provided herein are compositions and methods useful, inter alia, for the delivery of ribonucleoprotein complexes (e.g., Cas9/guide RNA complexes) into cells. The compositions and methods provided herein are particularly useful for the delivery of ribonucleoprotein complexes into pluripotent cells and lymphatic cells.
-
公开(公告)号:US20170254775A1
公开(公告)日:2017-09-07
申请号:US15597928
申请日:2017-05-17
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: John LEITE , Robert POPE , Mahbod HAJIVANDI , Xiquan LIANG
Abstract: The invention provides methods for quantifying biomolecules, such as polypeptides in mass spectrometric analysis. The methods include use of a biomolecule standard having at least one atomic isotope different than that of the naturally occurring isotopes in the biomolecule of interest. Methods of the present invention also include methods for quantifying biomolecules where the copy biomolecule standard is made by expressing the biomolecule using a recombinant cell. Further included are the biomolecule standards themselves, method for making such standards, kits, systems, reagents, and engineered cells relating to the use of biomolecule standards in mass spectrometric analysis.
-
公开(公告)号:US20240247286A1
公开(公告)日:2024-07-25
申请号:US18374673
申请日:2023-09-29
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Xiquan LIANG , Robert Jason POTTER , Lansha PENG
IPC: C12N15/90 , C07K14/195 , C12N9/22 , C12N15/63
CPC classification number: C12N15/907 , C07K14/195 , C12N9/22 , C12N15/63 , C12N2800/80 , C12N2800/95 , C12N2810/40
Abstract: The present disclosure relates to methods, kits, and compositions for improving the efficiency of homologous recombination. In particular, the disclosure relates to methods for cloning DNA molecules directly into a genome with the combined use of promoter trapping and short homology arms, nuclear localization signal, and/or binding one or more DNA binding agents (TAL effector domain or truncated guide RNA bound by Cas9) to specific sites thereby displacing or restructuring chromatin at the target locus, and/or it increasing the accessibility of the target locus to further enzymatic modifications. The methods and compositions provided herein are, inter alia, useful for genome editing and enhancing enzymatic processes involved therein.
-
公开(公告)号:US20230151345A1
公开(公告)日:2023-05-18
申请号:US18071206
申请日:2022-11-29
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Robert POTTER , Jonathan CHESNUT , Xiquan LIANG
CPC classification number: C12N9/22 , C12N15/11 , C12N15/907 , C12N2310/20 , C12N2800/80
Abstract: The present disclosure generally relates to compositions and methods for improving the efficiency of homologous recombination. In particular, the disclosure relates to reagents and the use of such reagents.
-
公开(公告)号:US20200299729A1
公开(公告)日:2020-09-24
申请号:US16644445
申请日:2018-09-07
Applicant: LIFE TECHNOLOGIES CORPORATION
Inventor: Chi-Hsuan CHANG , Xiquan LIANG
IPC: C12N15/87 , C12N15/11 , C12N9/22 , C12N5/0783
Abstract: The present disclosure relates to methods, kits, and compositions for improving the efficiency of homologous recombination. In particular, the disclosure relates to methods for introducing a nucleic acid cutting entity for DNA editing into cells that are difficult to transfect. Generally, the nucleic acid cutting entity is introduced into the cell without the use of viral vectors. The disclosure also relates to cloning DNA molecules directly into a genome with the combined use of promoter trapping and short homology arms, nuclear localization signal, and/or binding one or more DNA binding agents (TAL effector domain or truncated guide RNA bound by Cas9) to specific sites thereby displacing or restructuring chromatin at the target locus, and/or it increasing the accessibility of the target locus to further enzymatic modifications. The methods and compositions provided herein are, inter alia, useful for genome editing and enhancing enzymatic processes involved therein.
-
-
-
-
-
-
-
-
-